WalkMe is a cloud-based Digital Adoption Platform enabling organizations to effectively accelerate Coupa user adoption, measure digital transformations, and quickly achieve software ROI.
Acquis can implement your customized WalkMe solutions to deliver real-time enduser training, drive engagement, maximize productivity and gather insights on your organization’s usage of Coupa.
Automate User Onboarding
Create Smart Walk-thrus
Interactive Action Bots
Increase Coupa Adoption
Drive Self-Service Support
Increase Compliance
Acquis leverages years of spend and expense management experience to support our clients with successful Coupa deployment. With a focus on achieving a rapid ROI, Acquis follows rigorous standard deployment methodologies. We also understand many clients appreciate additional consulting and assistance developing their procurement policies. Acquis is agile to support all of our clients’ needs and understands while we have a standard tool, each client will approach the deployment with their unique definition of success.
Reach out to the Acquis team
Tags:
For decades, procurement and finance have been uneasy allies. One holds the purse strings. The other spends the money. In theory, they share the same goals. In reality, they often operate at cross-purposes — slowing each other down, duplicating efforts, and moving out of sync.
Read More
Over the next decade, biopharma success will be determined not by the most ambitious science or the largest balance sheets, but by leadership — specifically, by companies that can navigate the industry's bifurcation and develop fluency in the Alliance Economy. Others will likely face acquisition or marginalization.
Read More
Leading PE firms are using AI to eliminate data latency, reduce churn, and transform quarterly reviews into continuous portfolio intelligence.
Read More
For decades, procurement and finance have been uneasy allies. One holds the purse strings. The other spends the money. In theory, they share the same goals. In reality, they often operate at cross-purposes — slowing each other down, duplicating efforts, and moving out of sync.
Read More
Over the next decade, biopharma success will be determined not by the most ambitious science or the largest balance sheets, but by leadership — specifically, by companies that can navigate the industry's bifurcation and develop fluency in the Alliance Economy. Others will likely face acquisition or marginalization.
Read More
Leading PE firms are using AI to eliminate data latency, reduce churn, and transform quarterly reviews into continuous portfolio intelligence.
Read More
